Interstitial lung disease

  • Generic term used to describe a number of conditions that primarily affect the lung parenchyma in a diffuse manner
  • They are characterised by chronic inflammation and or progressive fibrosis and share a number of clinical and pathological features

 

Clinical features

  • Dyspnoea on exertion
  • Non productive cough
  • Abnormal breath sounds
  • Restrictive spirometry

 

Pathological features

  • Fibrosis and remodelling of the interstitium
  • Chronic inflammation
  • Hyperplasia of type II pneumocytes

 

Classification;

  • Those with a known aetiology;
    • Occupational/environmental – asbestosis, berylliosis, silicosis
    • Drugs – nitroflurantoin, bleomycin, amiodarone, sulfasalazine, busulfan
    • Hypersensitivity reactions – extrinsic allergic alveolitis
    • Infections – TB, fungi, viral
  • Those associated with systemic disorders;
    • Sarcoidosis
    • RA
    • SLE, systemic sclerosis, mixed CT diseases, Sjogren’s syndrome
    • UC, renal tubular acidosis, autoimmune thyroid disease
  • Idiopathic
    • Idiopathic pulmonary fibrosis (IPF)/cryptogenic fibrosing alveolitis
    • Cryptogenic organising pneumonia
    • Lymphocytic organising pneumonia

 

 

Extrinsic allergic alveolitis

  • In sensitized people, inhalation of allergens (fungal spores or avian proteins) provokes a hypersensitivity reaction
  • In the acute phase, the alveoli are infiltrated with acute inflammatory cells
  • With the chronic phase, granuloma formation and obliterative bronchiolitis occur

 

Causes;

  • Bird fanciers and pigeon fanciers lung
  • Farmers and mushroom workers lung
  • Malt workers lung
  • Bagassosis

 

Clinical features

  • 4-6hr post-exposure
  • Fever, rigors, myalgia, dry cough, crackles
  • Chronic
  • Increasing dyspnoea, weight loss, exertional dyspnoea, type I respiratory failure, cor pulmonale

 

Tests

  • Acute
    • Bloods – raised neutrophils, raised ESR, positive serum precipitans (indicates exposure only)
    • CXR – mid-zone mottling/consolidation, hilar lymphadenopathy
    • Lung function tests – reversible restricted defect
  • Chronic
    • Bloods – positive serum precipitans
    • CXR – upper zone fibrosis, honey comb lung
    • Lung function tests – persistent changes
    • BAL – increased lymphocytes and mast cells

 

Management

  • Acute attack- remove allergen, give oxygen. Give oral prednisolone 40mg/24hr

 

 

Idiopathic pulmonary fibrosis

 

  • Inflammatory cell infiltrate and pulmonary fibrosis of unknown cause
  • Also known as cryptogenic fibrosing alveolitis
  • The commonest cause of interstitial lung disease

 

Symptoms

  • Dry cough, exertional dyspnoea, malaise, weight loss, arthralgia

 

Signs

  • Cyanosis, finger clubbing, fine end inspiratory crackles

 

Complications

  • Type I respiratory failure
  • Increased risk of cancer

 

Tests

  • Bloods
  • ABG, raised CRP, Ig ANA
  • CXR – decreased lung volume, bilateral lower zone reticular nodular shawdowing, honeycomb lung
  • Spirometry – restrictive
  • BAL – increased lymphocytes (good response), or neutrophils and eosinophils (poor response)
  • Lung biopsy

 

Management

  • A large proportion have chronic irreversible disease unresponsive to treatment
  • Prednisolone 0.5mg/kg/24hr for 4 wk then 0.25mg/kg/24hr for 48wk
  • Monitor response via symptom enquiry, CXR and lung function tests
  • May consider lung transplantation

 

Prognosis

  • 50% 5 yr survival rate

 

Interstitial dust diseases

 

Coal workers pneumoconiosis (CWP)

  • Inhalation of coal dust particles
  • Ingested by macrophages which die releasing their enzymes which are fibrotic
  • Clinical features
  • Asymptomatic but co-existing bronchitis is common
  • CXR may show round opacities especially in upper zone
  • Progressive massive fibrosis (PMF) is due to progression of CWP which causes progressive dyspnoea, fibrosis and eventually cor pulmonale
  • CXR – upper zone fibrotic masses
  • Caplan’s syndrome is the association between RA, pneumoconiosis and pulmomary rheumatoid nodules

 

Silicosis

  • Inhalation of silica particles which are very fibrinogenic
  • Clinical features;
  • Progressive dyspnoea, increased incidence of TB, CXR shows diffuse military or nodular pattern in upper and mid-zones and egg shell calcification of hilar nodes

 

Asbestosis

  • Causes by inhalation of asbestos fibers
  • Chrysotile (white asbestos) is the least fibrogenic, crocidolite (blue asbestos) is the most fibrogenic
  • Clinical features;
  • Progressive dyspnoea, clubbing, fine inspiratory crackles. Also causes pleural plaques, increased risk of bronchial adenocarcinoma and mesothelioma

 

Malignant mesothelioma

  • Tumour of the mesothelial cells, usually occurs in the pleural and rarely in the peritoneum or other organs
  • Clinical features
  • Chest pain, dyspnoea, weight loss, finger clubbing, pleural effusions
  • If tumour has metastasized there may be lymphadenopathy, hepatomegaly, bone pain, abdominal pain/obstruction
  • Test
  • CXR/CT – pleural thickening
  • Diagnosis is made on pleural biopsy
  • Prognosis is very poor, less than 2 years

Leave a Reply



Disclaimer: These notes are my own personal study aid - DO NOT use them for medical advice!